About this trial
This study evaluates changes in hunger perception and body composition-related measures following daily use of a commercially available dietary supplement formulated to support leptin-related metabolic signaling. Adult participants will self-administer the supplement for 12 weeks and complete periodic self-reported assessments related to appetite, hunger, and weight-related outcomes. Participants serve as their own control, with comparisons made between baseline and follow-up measurements. The study is designed to generate preliminary, real-world evidence regarding supplement use in a general wellness context.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults aged 18 years or older
Willing to pay for study supplies and able to take the dietary supplement daily for 12 weeks
Willing to complete electronic questionnaires and self-reported measurements
Able to provide informed consent
Disqualifiers
Pregnant or breastfeeding individuals
Known allergy or sensitivity to any supplement ingredients
Use of medications or supplements that could interfere with appetite or weight without medical clearance
Any medical condition that would make participation unsafe, as determined by the participant
Trial design
Single group
Treatments tested in this trial
Leptin Balance Formula
Dietary supplementParticipants will self-administer the Leptin Balance Formula daily for 12 weeks according to product labeling. The supplement is commercially available and includes African mango seed extract, chromium picolinate, Ceylon cinnamon, and alpha lipoic acid.
Treatment groups
Trial outcomes
Primary outcomes
Change in Hunger Perception
Change from baseline in self-reported hunger perception as measured by a standardized hunger perception questionnaire.
Secondary outcomes
Change in Body Weight
Self-reported body weight change from baseline.
After-Meal Hunger and Fatigue Perception
Self-reported hunger and fatigue levels following meals using a structured questionnaire.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.